The global plasma fractionation market is expected to experience exponential growth owing to the growing worldwide demand for plasma-derived therapy coupled with rising prevalence of rare disorders among growing population.
According to the recently published report by Markntel Advisors, the Global Plasma Fractionation Market size was valued at around USD 31.18 billion in 2024 and is projected to reach USD 42.39 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 5.51% during the forecast period, i.e., 2025-30.
Key Market Drivers and Trends Fueling Growth
- Rising Demand for Immunoglobulins
- Growing Applications in Neurology
- Technological Innovations in Fractionation
- Stringent Regulatory Approvals
Regional Insights: Asia-Pacific Leading the Charge
- North America – The region is predicted to consistent the steady growth owing to the high healthcare expenditure and an established biopharmaceutical industry.
- Europe – The region is emphasizing towards increasing government investments in plasma-derived therapies.
- Asia-Pacific – Witnessing the lucrative growth due to expanding blood plasma collection centers, rising healthcare infrastructure, and a growing patient base for immune disorders.
- South America & Middle East – Emerging markets showing potential growth, driven by increasing awareness and government initiatives.
Challenges & Opportunities in the Plasma Fractionation Market
Challenges:
- High Cost of Plasma-Derived Therapies
- Stringent Regulatory Frameworks
Opportunities:
- Advancements in Recombinant Technologies
- Rising Collaborations and Mergers
Key Players Driving the Market Growth
- Biotest A.G.,
- Octapharma A.G.,
- Adma Biologics,
- Aegros,
- CSL Limited,
- Grifols S.A.,
- Kedrion Biopharma Inc.,
- Bio Products Laboratory Ltd,
- Takeda Pharmaceuticals,
- Emergent Bio Solutions,
- Intas Pharmaceutical,
- Plasma Gen Biosciences,
- S K Plasma,
- Australian Red Cross Lifeblood, and Others
Global Plasma Fractionation Market Segmentation Analysis
The industry is further bifurcated into:
Based on Product:
- Immunoglobulin
- Coagulation Factors
- Albumin,
- Protease Inhibitor,
- Others
By Application:
- Neurology,
- Immunology,
- Hematology,
- Critical Care,
- Pulmonology,
- Rheumatology,
- Others (Oncology, Pediatrics, etc.)
By End User:
- Hospitals,
- Specialty Clinics,
- Research Facilities
Future Outlook
As per the analytical report the industry is anticipated to grow & flourish during the forecast period as above-stated factors are changing market landscape and opening doors to the market players. Market players can enhance their market size & revenue through meeting with the changing market dynamics and evolving consumers’ expectations. Additionally, market players with the help of SWOT analysis can adjust their existing settings with reference to the evolving market trends, which would ultimately augment the size & volume of the entire industry at global level.
Key Questions Answered in the Research Report
- What is the predicted Keyword market size and growth rate for the years 2025-30?
- What challenges are restricting the growth of the keyword market?
- What are the key Drivers, Trends, and opportunities defining the keyword market size?
- Which segment accounted for the largest market share in the keyword market?
- Which region has the maximum potential for the keyword market?
- Which prominent companies are leading growth in the keyword market?
- In what formats does Markntel Advisors deliver the concerned report descriptions?
- How long does it take for customers to receive the reports provided by Markntel Advisors?
- Does Markntel Advisors provide customized reports?
About Us –
MarkNtel Advisors is a leading consulting, data analytics, and market research firm that provides an extensive range of strategic reports on diverse industry verticals. We being a qualitative & quantitative research company, strive to deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, and individuals, among others.
We have our existence across the market for many years and have conducted multi-industry research across 80+ countries, spreading our reach across numerous regions like America, Asia-Pacific, Europe, the Middle East & Africa, etc., and many countries across the regional scale, namely, the US, India, the Netherlands, Saudi Arabia, the UAE, Brazil, and several others.
Media Contact:
Company Name: MarkNtel Advisors
Email: sales@marknteladvisors.com
Website: www.marknteladvisors.com/
Phone: +1 628 895 8081, +91 70 4278433
Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh – 201301, India
Leave a Reply